DÄ internationalArchive22/2007Clostridium Difficile Associated Diseases – an Emerging Problem

Review article

Clostridium Difficile Associated Diseases – an Emerging Problem

Dtsch Arztebl 2007; 104(22): A-1588

Schneider, T; Eckmanns, T; Ignatius, R; Weist, K; Liesenfeld, O

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

1. Kuijper EJ, van den Berg RJ, Debast S et al.: Clostridium difficile ribotype 027, toxinotype III, the Netherlands. Emerg Infect Dis 2006; 12: 827–30. MEDLINE
2. Kyne L, Hamel MB, Polavaram R, Kelly CP: health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002; 34: 346–53. MEDLINE
3. Robert-Koch-Institut, Epidemiologisches Bulletin 36/2006, www.rki.de
4. Tedesco FJ, Barton RW, Alpers DH: Clindamycin-associated colitis. A prospective study. Ann Intern Med 1974; 81: 429–33. MEDLINE
5. Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL: Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis 1977; 136: 701–5. MEDLINE
6. Sebaihia M, Wren BW, Mullany P et al.: The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet 2006; 38: 779–86. MEDLINE
7. Bartlett JG: Narrative Review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 2006; 145: 758–64. MEDLINE
8. Cloud J, Kelly CP: Update on Clostridium difficile-associated disease. Curr Opin Gastroenterol 2007; 23: 4–9. MEDLINE
9. McDonald LC, Killgore GE, Thompson A et al.: An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353: 2433–41. MEDLINE
10. McFarland LV, Mulligan ME, Kwok RY, Stamm WE: Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320: 204–10. MEDLINE
11. Schroder O, Gerhard R, Stein J: Antibiotika-assoziierte Diarrhö. Z Gastroenterol 2006; 44: 193–204. MEDLINE
12. McDonald LC, Owings M, Jernigan DB: Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996–2003. Emerg Infect Dis 2006; 12: 409–15. MEDLINE
13. Kuijper EJ, Coignard B, Tull P: The ESCMID Study Group for Clostridium Difficile (ESGCD): emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006; 12 (Suppl 6): 2–18. MEDLINE
14. Centers for Disease Control and Prevention (CDC): Severe Clostridium difficile-associated disease in populations previously at low risk – four states. MMWR Morb Mortal Wkly Rep 2005; 54: 1201–5. MEDLINE
15. Heimesaat MM, Granzow K, Leidinger H, Liesenfeld O: Prevalence of Clostridium difficile toxins A and B and Clostridium perfringens enterotoxin A in stool samples of patients with antibiotic-associated diarrhea. Infection 2005; 33: 340–4. MEDLINE
16. Ash L, Baker ME, O'Malley CM Jr et al.: Colonic abnormalities on CT in adult hospitalized patients with Clostridium difficile colitis: prevalence and significance of findings. American Journal of Radiology 2006; 186: 1393–400. MEDLINE
17. Bricker E, Garg R, Nelson R et al.: Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Cochrane Database Syst Rev(1) 2005; CD004610. MEDLINE
18. Fekety R: Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 1997; 92: 739–50. MEDLINE
19. Fernandez A, Anand G, Friedenberg F: Factors associated with failure of metronidazole in Clostridium difficile-associated disease. J Clin Gastroenterol 2004; 38: 414–8. MEDLINE
20. Pepin J, Valiquette L, Alary ME et al.: Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. Cmaj 2004; 171: 466–72. MEDLINE
21. Suarawicz CM: Treatment of recurrent Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol & Hepatol 2004; 1: 32–8. MEDLINE
22. McFarland LV, Surawicz CM, Greenberg RN et al.: A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. Jama 1994; 271: 1913–8. MEDLINE
23. Babcock GJMR, Coccia JA, Esshaki DJ et al.: Human monoclonal antibody against toxin A protects hamsters from Clostridium difficile disease. Paper presented at the 42nd Annual Meeting of the Infectious Disease Society of America. Boston 2004.
24. Louie TJ, Peppe J, Watt CK et al.: Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment mild to moderately severe Clostridium difficile-associated diarrhea. Clin Infect Dis 2006; 43: 411–20. MEDLINE
25. Koss K, Clark MA, Sanders DS et al.: The outcome of surgery in fulminant Clostridium difficile colitis. Clorectal Dis 2006; 8: 149–54. MEDLINE
26. Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J Jr.: Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995; 16: 459–77. MEDLINE